PRP Dosing Is MUCH More Complicated than It Looks

By /

Receive a Regenexx® Patient Info Packet by email and learn why it's a superior regenerative solution.

By submitting the form, you are agreeing that you read and consent to our Privacy Policy. We may also contact you via email, phone, and other electronic means to communicate information about our products and services. We do not sell, or share your information to third party vendors. Your submitted information is used only for the purposes of providing you with information about Regenexx.

dosing prp

I had a recent clinical research meeting with our fellows and one of the topics brought up was PRP dosing. They thought that this was a simple matter of counting the platelets. However, once I explained how complex PRP dosing really was, their minds had exploded. Hence, I told them that I would blog on it.

PRP and Classification Systems

PRP stands for platelet-rich plasma. This means that the doctor takes a blood sample and uses a centrifuge to concentrate the platelets in your plasma. These platelets contain healing growth factors that can help damaged tissues.

There are several different types of PRP, but the two main types commonly used for injection include the “red” leukocyte rich variety and the “amber” leukocyte poor type. These are red and amber because the red blood cells come along for the ride with the white blood cells (leukocytes). Meaning leukocyte rich has lots of red blood cells as well and leukocyte poor has few.

While several classification systems for PRP have been proposed, the one that seems to be used the most often is the PLRA (1).  This means that to classify PRP, we need to know the platelet count (P), the leukocyte content (L), the red blood cell content (R) and whether or not the PRP was activated (A). However, as I’ll show below, while this is a good start, quantifying or dosing PRP is actually MUCH more complicated.

Counting Platelets in PRP Can Be Unreliable at Best

Counting platelets in whole blood is easy and done every day. However, counting platelets in PRP is harder. Why? All of that centrifugation that’s needed to concentrate the platelets causes some to clump together in doublets and triplets. So when you look at PRP under the microscope, you tend to see a reasonable number of platelets stuck together. Cell counters will either count these double or triple platelets as one platelet or just ignore them because the counter believes these are larger red or white blood cells. Meaning that counting platelet numbers in PRP is usually inaccurate.

All Platelets are Not Created Equal

The first thing that blew the collective minds of my fellows was the fact that the growth factor content of platelets varies widely between patients. Remember that platelets have growth factors that live in alpha vesicles and then those vesicles degranulate over about a week. That means they release their growth factors out of the cell into the local environment. However, the number of growth factors packed into each platelet varies widely. For example, this GF content usually drops as the patient ages and with gender (2).

In addition, the timing and pattern of the GF release depends on what’s in the local microenvironment. Meaning unlike a pill dissolving in water, which GFs the platelet releases and when depends on what the platelet senses. For example, just by varying the levels of calcium and thrombin in the mix, one author was able to get widely different GFs to degranulate at different times (3). So to continue our pill analogy, platelets are “smart pills”.

Cellular Response to Platelet GFs Varies Widely with Age

We’ve been studying how different cells react to platelets for more than a decade. Remember that the GFs in platelets can act like espresso shots for the local cells. Hence, more GFs coming out of more platelets can get cells to grow more quickly (proliferate) or get cells with a specific job (like tenocytes) to repair a gap faster. However, these espresso shot effects of platelets tend to max out at lower doses with younger cells while older cells have a direct dose-response relationship all the way up to 20-40X (4). Meaning that if you double the platelet concentration (2X PRP) and compare how cells react to that compared to a 5X PRP, young cells won’t show much difference. However, do the same experiment with older cells and they will show much more proliferation with the 5X over the 2X.

Why does this happen? My thought is that it’s related to receptors. Remember that GFs from platelets must bind to receptors on the target cell to stimulate a response. The body is good at altering the density of those receptors on the cell based on what’s needed. Meaning, place cells in a GF rich environment like a young body and the cell will reduce the number of receptors on its surface. The opposite happens when the cell is placed in a GF poor environment (like an old body). The cells then ramp up the receptor density to take advantage of the few GFs floating around. So when we flood lots of GFs around receptor poor young cells, they can’t take advantage of the extra GFs as their few receptors fill up quickly. However, the greater number of receptors on old cells can take advantage of those higher GF concentrations.

Why Young Minds Were Blown

After giving this little talk in front of my fellows, I could tell their brains were now strewn all over the conference table. Meaning, they believed that the PLRA system was all that you needed to quantify and classify PRP. While it’s a great start, they could see that it wasn’t close to telling the whole story about PRP from a research standpoint. So what’s needed?

  • A device that can accurately count platelet doublets and triplets in PRP as two and three platelets. With advances in AI, we will get there.
  • A device that can determine the GF content of the platelets.
  • Measurements of the microenvironment where platelets are being introduced.
  • A recognition that younger people will respond differently to PRP dosing than older people. Perhaps a measurement of receptor density on cells?

The upshot? As you can see, we still have much to learn to more accurately dose PRP. While PLRA is a great start, it’s not close to quantifying and classifying everything about PRP. However, I have faith that the next generation of regenerative medicine researchers (as represented by those mind blown fellows) will solve these problems. Hopefully, by then, I’ll be sipping a rum drink on some beach somewhere!

____________________________________________

References:

(1) Mautner, Kenneth & Malanga, Gerard & Shiple, Brian & Ibrahim, Victor & Sampson, Steven & Bowen, Jay. (2015). A Call for a Standard Classification System for Future Biologic Research: The Rationale for New PRP Nomenclature. PM&R. 7. 10.1016/j.pmrj.2015.02.005.

(2) Evanson R, et al. Gender and Age Differences in Growth Factor Concentrations
From Platelet-Rich Plasma in Adults. MILITARY MEDICINE, 179, 7:799, 2014. Link to artcile. 

(3) Martineau, I & Lacoste, E & Gagnon, G. (2004). Effects of calcium and thrombin on growth factor release from platelet concentrates: Kinetics and regulation of endothelial cell proliferation. Biomaterials. 25. 4489-502. 10.1016/j.biomaterials.2003.11.013.

(4) D. R. Berger, C. J. Centeno, and N. J. Steinmetz. Platelet lysates from aged donors promote human tenocyte proliferation and migration in a concentration-dependent manner. Bone & Joint Research 2019 8:1, 32-40. Link to artcile. 

Category: Uncategorized

Leave a Reply

Your email address will not be published. Required fields are marked *

2 thoughts on “PRP Dosing Is MUCH More Complicated than It Looks

  1. Joan Kleynhans

    I had stem cell treatment about 15 months ago. It helped a lot but not 100%. My knees are aching more frequently again. Will I benefit from PRP treatment at this stage? I am a 70 yr old woman.

    1. Regenexx Team

      Hi Joan,
      Likely a good idea. Please see: https://regenexx.com/blog/knee-arthritis-stem-cell-treatment/

Chris Centeno, MD

Regenexx Founder

Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications.
View Profile

Get Blog Updates by Email

Get fresh updates and insights from Regenexx delivered straight to your inbox.

By submitting the form, you are agreeing that you read and consent to our Privacy Policy. We may also contact you via email, phone, and other electronic means to communicate information about our products and services. We do not sell, or share your information to third party vendors. Your submitted information is used only for the purposes of providing you with information about Regenexx.

Find a Regenexx Provider

Regenexx is a world-wide network of specially trained physicians providing the world's most advanced, research-driven, regenerative-medicine treatments in North America, Europe, the Middle East, Asia and Australia.

Regenerative procedures are commonly used to treat musculoskelatal trauma, overuse injuries, and degenerative issues, including failed surgeries.
Select Your Problem Area
Shoulder

Shoulder

Many Shoulder and Rotator Cuff injuries are good candidates for regenerative treatments. Before considering shoulder arthroscopy or shoulder replacement, consider an evaluation of your condition with a regenerative treatment specialist.

  • Rotator Cuff Tears and Tendinitis
  • Shoulder Instability
  • SLAP Tear / Labral Tears
  • Shoulder Arthritis
  • Other Degenerative Conditions & Overuse Injuries
Learn More
Cervical Spine

Spine

Many spine injuries and degenerative conditions are good candidates for regenerative treatments and there are a number of studies showing promising results in treating a wide range of spine problems. Spine surgery should be a last resort for anyone, due to the cascade of negative effects it can have on the areas surrounding the surgery. And epidural steroid injections are problematic due to their long-term negative impact on bone density.

  • Herniated, Bulging, Protruding Discs
  • Degenerative Disc Disease
  • SI Joint Syndrome
  • Sciatica
  • Pinched Nerves and General Back Pain
  • And more
Learn More
Knee

Knees

Knees are the target of many common sports injuries. Sadly, they are also the target of a number of surgeries that research has frequently shown to be ineffective or minimally effective. Knee arthritis can also be a common cause for aging athletes to abandon the sports and activities they love. Regenerative procedures can be used to treat a wide range of knee injuries and conditions. They can even be used to reduce pain and delay knee replacement for more severe arthritis.

  • Knee Meniscus Tears
  • Knee ACL Tears
  • Knee Instability
  • Knee Osteoarthritis
  • Other Knee Ligaments / Tendons & Overuse Injuries
  • And more
Learn More
Lower Spine

Spine

Many spine injuries and degenerative conditions are good candidates for regenerative treatments and there are a number of studies showing promising results in treating a wide range of spine problems. Spine surgery should be a last resort for anyone, due to the cascade of negative effects it can have on the areas surrounding the surgery. And epidural steroid injections are problematic due to their long-term negative impact on bone density.

  • Herniated, Bulging, Protruding Discs
  • Degenerative Disc Disease
  • SI Joint Syndrome
  • Sciatica
  • Pinched Nerves and General Back Pain
  • And more
Learn More
Hand & Wrist

Hand & Wrist

Hand and wrist injuries and arthritis, carpal tunnel syndrome, and conditions relating to overuse of the thumb, are good candidates for regenerative treatments. Before considering surgery, consider an evaluation of your condition with a regenerative treatment specialist.
  • Hand and Wrist Arthritis
  • Carpal Tunnel Syndrome
  • Trigger Finger
  • Thumb Arthritis (Basal Joint, CMC, Gamer’s Thumb, Texting Thumb)
  • Other conditions that cause pain
Learn More
Elbow

Elbow

Most injuries of the elbow’s tendons and ligaments, as well as arthritis, can be treated non-surgically with regenerative procedures.

  • Golfer’s elbow & Tennis elbow
  • Arthritis
  • Ulnar collateral ligament wear (common in baseball pitchers)
  • And more
Learn More
Hip

Hip

Hip injuries and degenerative conditions become more common with age. Do to the nature of the joint, it’s not quite as easy to injure as a knee, but it can take a beating and pain often develops over time. Whether a hip condition is acute or degenerative, regenerative procedures can help reduce pain and may help heal injured tissue, without the complications of invasive surgical hip procedures.

  • Labral Tear
  • Hip Arthritis
  • Hip Bursitis
  • Hip Sprain, Tendonitis or Inflammation
  • Hip Instability
Learn More
Foot & Ankle

Foot & Ankle

Foot and ankle injuries are common in athletes. These injuries can often benefit from non-surgical regenerative treatments. Before considering surgery, consider an evaluation of your condition with a regenerative treatment specialist.
  • Ankle Arthritis
  • Plantar fasciitis
  • Ligament sprains or tears
  • Other conditions that cause pain
Learn More

Is Regenexx Right For You?

Request a free Regenexx Info Packet

REGENEXX WEBINARS

Learn about the #1 Stem Cell & Platelet Procedures for treating arthritis, common joint injuries & spine pain.

Join a Webinar

RECEIVE BLOG ARTICLES BY EMAIL

Get fresh updates and insights from Regenexx delivered straight to your inbox.

Subscribe to the Blog

CONTACT US

9035 Wadsworth Pkwy #1000
Westminster, CO 80021
888-525-3005

FOLLOW US

Copyright © Regenexx 2020. All rights reserved. | Privacy Policy

*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.

LinkedIn
Email